{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:01Z","timestamp":1786505221287,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of the review<\/jats:title>\n                    <jats:p>This review provides an overview of the pharmacodynamics and pharmacokinetics of buprenorphine followed by a review of the published research on the perioperative use of buprenorphine for acute postoperative pain, and analgesia management in patients already on buprenorphine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Current evidence comparing buprenorphine with full opioid agonists is heterogeneous, showing either modest superiority or comparable analgesic efficacy, with a reduced incidence of certain adverse effects such as respiratory depression. Despite concerns that its high receptor affinity may limit the efficacy of additional opioids, buprenorphine can be safely combined with other opioid agonists for breakthrough and perioperative pain. Perioperative management requires an individualized, interdisciplinary approach, taking into account patient-specific risk factors. Multimodal analgesia\u2014including regional techniques, non-opioid medications, adjunctive agents, and nonpharmacological strategies\u2014forms the cornerstone of effective perioperative pain control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A structured postoperative plan with dose adjustment, coordinated follow-up, and collaboration with outpatient prescribers is critical. Early involvement of the Acute Pain Services team could be beneficial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11916-026-01545-w","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:28:30Z","timestamp":1786501710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Individualized, Interdisciplinary Approach to the Perioperative Care of Patients on Buprenorphine"],"prefix":"10.1007","volume":"30","author":[{"given":"Egor","family":"Harin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vighnesh","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Andereggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M","family":"Luedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"1545_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14622416.2025.2546770","volume":"26","author":"L Aravindan","year":"2025","unstructured":"Aravindan L, Velu S, Sivam I, Sivam S, Tallapaneni P, Ressler R, et al. Pharmacogenomics of buprenorphine: a narrative review. Pharmacogenomics. 2025;26:263\u201370.","journal-title":"Pharmacogenomics"},{"key":"1545_CR2","unstructured":"Kumar R, Viswanath O, Saadabadi A, Buprenorphine. [Updated 2024 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan\u2013. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459126\/"},{"key":"1545_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.semperi.2019.01.001","volume":"43","author":"J Lyden","year":"2019","unstructured":"Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019;43:123\u201331.","journal-title":"Semin Perinatol"},{"key":"1545_CR4","unstructured":"Preuss CV, Kalava A, King KC. Prescription of controlled substances: benefits and risks. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jul 6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537318\/"},{"key":"1545_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/02791072.2019.1566583","volume":"51","author":"T Molfenter","year":"2019","unstructured":"Molfenter T, Fitzgerald M, Jacobson N, McCarty D, Quanbeck A, Zehner M. Barriers to buprenorphine expansion in Ohio: a time-elapsed qualitative study. J Psychoact Drugs. 2019;51:272\u20139.","journal-title":"J Psychoact Drugs"},{"key":"1545_CR6","doi-asserted-by":"publisher","first-page":"E189","DOI":"10.1097\/JAN.0000000000000392","volume":"34","author":"A Spayde-Baker","year":"2023","unstructured":"Spayde-Baker A, Patek J. A comparison of medication-assisted treatment options for opioid addiction: a review of the literature. J Addict Nurs. 2023;34:E189\u201394.","journal-title":"J Addict Nurs"},{"key":"1545_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bja.2017.11.086","volume":"120","author":"LD White","year":"2018","unstructured":"White LD, Hodge A, Vlok R, Hurtado G, Eastern K, Melhuish TM. Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials. Br J Anaesth. 2018;120:668\u201378.","journal-title":"Br J Anaesth"},{"key":"1545_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/sja.sja_822_22","volume":"17","author":"MS Albaqami","year":"2023","unstructured":"Albaqami MS, Alqarni AA, Alabeesy MS, Alotaibi AN, Alharbi HA, Alshammari MM, et al. Buprenorphine for acute post-surgical pain: a systematic review and meta-analysis. Saudi J Anaesth. 2023;17:65\u201371.","journal-title":"Saudi J Anaesth"},{"key":"1545_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/rapm-2024-106014","volume":"51","author":"TR Hickey","year":"2026","unstructured":"Hickey TR, Costa GPA, Oliveira D, Podosek A, Abelleira A, Avila-Quintero VJ, et al. Buprenorphine versus full agonist opioids for acute postoperative pain management: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2026;51:1\u201316.","journal-title":"Reg Anesth Pain Med"},{"key":"1545_CR10","first-page":"1","volume":"52","author":"SRJ Maxwell","year":"2024","unstructured":"Maxwell SRJ. Pharmacodynamics and pharmacokinetics for the prescriber. Med (Abingdon). 2024;52:1\u201310.","journal-title":"Med (Abingdon)"},{"key":"1545_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0376-8716(03)00188-1","volume":"72","author":"SD McAleer","year":"2003","unstructured":"McAleer SD, Mills RJ, Polack T, Hussain T, Rolan PE, Gibbs AD, et al. Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid-naive healthy male volunteers under a naltrexone block. Drug Alcohol Depend. 2003;72:75\u201383.","journal-title":"Drug Alcohol Depend"},{"key":"1545_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40122-022-00380-2","volume":"11","author":"LR Webster","year":"2022","unstructured":"Webster LR, Cater J, Smith T. Pharmacokinetics of buprenorphine buccal film and orally administered oxycodone in a respiratory study: a secondary analysis of outcomes from a randomized controlled trial. Pain Ther. 2022;11:817\u201325.","journal-title":"Pain Ther"},{"key":"1545_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/009127009703700106","volume":"37","author":"J Mendelson","year":"1997","unstructured":"Mendelson J, Upton RA, Everhart ET, Jacob P, Jones RT. Bioavailability of sublingual buprenorphine. J Clin Pharmacol. 1997;37:31\u20137.","journal-title":"J Clin Pharmacol"},{"key":"1545_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11916-016-0549-9","volume":"20","author":"S Sen","year":"2016","unstructured":"Sen S, Arulkumar S, Cornett EM, Gayle JA, Flower RR, Fox CJ, et al. New pain management options for the surgical patient on methadone and buprenorphine. Curr Pain Headache Rep. 2016;20:16.","journal-title":"Curr Pain Headache Rep"},{"key":"1545_CR15","first-page":"E1","volume":"21","author":"AB Jonan","year":"2018","unstructured":"Jonan AB, Kaye AD, Urman RD. Buprenorphine formulations: clinical best practice strategies recommendations for perioperative management of patients undergoing surgical or interventional pain procedures. Pain Physician. 2018;21:E1\u201312.","journal-title":"Pain Physician"},{"key":"1545_CR16","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jpain.2023.07.001","volume":"24","author":"B Aguilar","year":"2023","unstructured":"Aguilar B, Penm J, Liu S, Patanwala AE. Efficacy and safety of transdermal buprenorphine for acute postoperative pain: a systematic review and meta-analysis. J Pain. 2023;24:1905\u201314.","journal-title":"J Pain"},{"key":"1545_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1124\/dmd.105.003681","volume":"33","author":"N Picard","year":"2005","unstructured":"Picard N, Cresteil T, Djebli N, Marquet P. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos. 2005;33:689\u201395.","journal-title":"Drug Metab Dispos"},{"key":"1545_CR18","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","volume":"60","author":"C Iribarne","year":"1997","unstructured":"Iribarne C, Picart D, Dr\u00e9ano Y, Bail JP, Berthou F. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci. 1997;60:1953\u201364.","journal-title":"Life Sci"},{"key":"1545_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1373\/clinchem.2008.113712","volume":"55","author":"SL Kacinko","year":"2009","unstructured":"Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clin Chem. 2009;55:1177\u201387.","journal-title":"Clin Chem"},{"key":"1545_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0090-9556(25)07765-7","volume":"12","author":"EJ Cone","year":"1984","unstructured":"Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE. The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos. 1984;12:577\u201381.","journal-title":"Drug Metab Dispos"},{"key":"1545_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41397-020-00198-1","volume":"21","author":"CW Meaden","year":"2021","unstructured":"Meaden CW, Mozeika A, Asri R, Santos CD. A review of the existing literature on buprenorphine pharmacogenomics. Pharmacogenomics J. 2021;21:128\u201339.","journal-title":"Pharmacogenomics J"},{"key":"1545_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1163\/156856903321579334","volume":"15","author":"K B\u00f6hme","year":"2003","unstructured":"B\u00f6hme K, Likar R. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain: a randomised, double-blind, placebo-controlled study. Pain Clin. 2003;15:193\u2013202.","journal-title":"Pain Clin"},{"key":"1545_CR23","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/pm\/pnx235","volume":"19","author":"T Priestley","year":"2018","unstructured":"Priestley T, Chappa AK, Mould DR, Upton RN, Shusterman N, Passik S, et al. Converting from transdermal to buccal formulations of buprenorphine: a pharmacokinetic meta-model simulation in healthy volunteers. Pain Med. 2018;19:1988\u201396.","journal-title":"Pain Med"},{"key":"1545_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.drugalcdep.2012.11.014","volume":"131","author":"MA Huestis","year":"2012","unstructured":"Huestis MA, Cone EJ, Pirnay SO, Umbritcht A, Preston KL. Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans. Drug Alcohol Depend. 2012;131:258\u201362.","journal-title":"Drug Alcohol Depend"},{"key":"1545_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clinthera.2005.02.012","volume":"27","author":"R Sittl","year":"2005","unstructured":"Sittl R, Likar R, Nautrup BP. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. Clin Ther. 2005;27:225\u201337.","journal-title":"Clin Ther"},{"key":"1545_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","volume":"44","author":"A Elkader","year":"2005","unstructured":"Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet. 2005;44:661\u201380.","journal-title":"Clin Pharmacokinet"},{"key":"1545_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jcpt.12196","volume":"39","author":"RB Raffa","year":"2014","unstructured":"Raffa RB, Haidery M, Huang HM, Kalladeen K, Lockstein DE, Ono H, et al. The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014;39:577\u201383.","journal-title":"J Clin Pharm Ther"},{"key":"1545_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ijnp\/pyy071","volume":"21","author":"KA Berg","year":"2018","unstructured":"Berg KA, Clarke WP. Making sense of pharmacology: inverse agonism and functional selectivity. Int J Neuropsychopharmacol. 2018;21:962\u201377.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1545_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","volume":"10","author":"J Pergolizzi","year":"2010","unstructured":"Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010;10:428\u201350.","journal-title":"Pain Pract"},{"key":"1545_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9:41\u201354.","journal-title":"Pain Ther"},{"key":"1545_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","volume":"59","author":"DA Volpe","year":"2011","unstructured":"Volpe DA, McMahon Tobin GA, Mellon RD, Katki AG, Parker RJ, et al. Uniform assessment and ranking of opioid \u00b5 receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59:385\u201390.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1545_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0963689718811060","volume":"28","author":"S Wang","year":"2019","unstructured":"Wang S. Historical review: opiate addiction and opioid receptors. Cell Transpl. 2019;28:233\u20138.","journal-title":"Cell Transpl"},{"key":"1545_CR33","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1007\/s11064-011-0525-z","volume":"36","author":"CW Lee","year":"2011","unstructured":"Lee CW, Yan JY, Chiang YC, Hung TW, Wang HL, Chiou LC, et al. Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human \u00b5-opioid and opioid receptor-like 1 receptors. Neurochem Res. 2011;36:2008\u201321.","journal-title":"Neurochem Res"},{"key":"1545_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuroscience.2008.06.027","volume":"155","author":"P Marquez","year":"2008","unstructured":"Marquez P, Borse J, Nguyen AT, Hamid A, Lutfy K. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine. Neuroscience. 2008;155:597\u2013602.","journal-title":"Neuroscience"},{"key":"1545_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001594","author":"M Heeney","year":"2025","unstructured":"Heeney M, Anderson E, Roller Sirey L, Benard R, Patregnani M, Lind K, et al. Extended-release buprenorphine for opioid use disorder in hospital and emergency department settings. J Addict Med. 2025. https:\/\/doi.org\/10.1097\/ADM.0000000000001594.","journal-title":"J Addict Med"},{"key":"1545_CR36","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","volume":"35","author":"M Buresh","year":"2020","unstructured":"Buresh M, Ratner J, Zgierska A, Gordin V, Alvanzo A. Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and practice recommendations. J Gen Intern Med. 2020;35:3635\u201343.","journal-title":"J Gen Intern Med"},{"key":"1545_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.mcna.2021.09.001","volume":"106","author":"T Hickey","year":"2022","unstructured":"Hickey T, Abelleira A, Acampora G, Becker WC, Falker CG, Nazario M, et al. Perioperative buprenorphine management: A multidisciplinary approach. Med Clin North Am. 2022;106:169\u201385.","journal-title":"Med Clin North Am"},{"key":"1545_CR38","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","volume":"28","author":"MK Greenwald","year":"2003","unstructured":"Greenwald MK, Johanson CE, Moody DE, Woods JH, Kilbourn MR, Koeppe RA, et al. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology. 2003;28:2000\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"1545_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/AJP.0b013e318241d948","volume":"28","author":"A Tr\u00f6ster","year":"2012","unstructured":"Tr\u00f6ster A, Ihmsen H, Singler B, Filitz J, Koppert W. Interaction of fentanyl and buprenorphine in an experimental model of pain and central sensitization in human volunteers. Clin J Pain. 2012;28:705\u201311.","journal-title":"Clin J Pain"},{"key":"1545_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/bja\/57.2.192","volume":"57","author":"RA Boas","year":"1985","unstructured":"Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine: the significance of receptor binding. Br J Anaesth. 1985;57:192\u20136.","journal-title":"Br J Anaesth"},{"key":"1545_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/rapm-2021-103007","volume":"46","author":"L Kohan","year":"2021","unstructured":"Kohan L, Potru S, Barreveld AM, Sprintz M, Lane O, Aryal A, et al. Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel. Reg Anesth Pain Med. 2021;46:840\u201359.","journal-title":"Reg Anesth Pain Med"},{"key":"1545_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/ijtm4030036","volume":"4","author":"A Desai","year":"2024","unstructured":"Desai A, Parikh S, Bergese S. Perioperative buprenorphine management and postoperative pain outcomes: a retrospective study with evidence-based recommendations. Int J Transl Med. 2024;4:539\u201346.","journal-title":"Int J Transl Med"},{"key":"1545_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/ALN.0000000000005291","volume":"142","author":"JM Hitt","year":"2024","unstructured":"Hitt JM, Elkin PL, de Leon-Casasola OA. Continuation versus interruption of buprenorphine\/naloxone in adult veterans undergoing surgery: examination of postoperative pain and opioid utilization in a national retrospective cohort study. Anesthesiology. 2024;142:320\u201331.","journal-title":"Anesthesiology"},{"key":"1545_CR44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/pm\/pny217","volume":"20","author":"AN Quaye","year":"2019","unstructured":"Quaye AN, Zhang Y. Perioperative management of buprenorphine: solving the conundrum. Pain Med. 2019;20:1395\u2013408.","journal-title":"Pain Med"},{"key":"1545_CR45","doi-asserted-by":"publisher","first-page":"158284","DOI":"10.52965\/001c.158284","volume":"18","author":"J Hasoon","year":"2026","unstructured":"Hasoon J, Nguyen A, Robinson CL. Managing acute surgical pain in patients on buprenorphine: a case-based learning module. Orthop Rev (Pavia). 2026;18:158284.","journal-title":"Orthop Rev (Pavia)"},{"key":"1545_CR46","first-page":"247","volume":"37","author":"Y Sritapan","year":"2020","unstructured":"Sritapan Y, Clifford S, Bautista A. Perioperative management of patients on buprenorphine and methadone: a narrative review. Balkan Med J. 2020;37:247\u201352.","journal-title":"Balkan Med J"},{"key":"1545_CR47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/pm\/pny019","volume":"20","author":"A Lembke","year":"2018","unstructured":"Lembke A, Ottestad E, Schmiesing C. Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through the peri-operative period. Pain Med. 2018;20:425\u20138.","journal-title":"Pain Med"},{"key":"1545_CR48","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/j.bja.2019.03.044","volume":"123","author":"A Goel","year":"2019","unstructured":"Goel A, Azargive S, Weissman JS, Shanthanna H, Hanlon JG, Samman B, et al. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process. Br J Anaesth. 2019;123:e333\u201342.","journal-title":"Br J Anaesth"},{"key":"1545_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13037-024-00392-1","volume":"18","author":"JR Burgess","year":"2024","unstructured":"Burgess JR, Heneghan KC, Barot TG, Stulberg JJ. Surgeons\u2019 knowledge regarding perioperative pain management in patients with opioid use disorder: a survey among 260 members of the American College of Surgeons. Patient Saf Surg. 2024;18:9.","journal-title":"Patient Saf Surg"},{"key":"1545_CR50","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jopan.2020.03.002","volume":"35","author":"EN Aroke","year":"2020","unstructured":"Aroke EN, McMullan SP, Woodfin KO, Richey R, Doss J, Wilbanks BA. A practical approach to acute postoperative pain management in chronic pain patients. J Perianesth Nurs. 2020;35:564\u201373.","journal-title":"J Perianesth Nurs"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01545-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:28:32Z","timestamp":1786501712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01545-w","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This review article complies with ethical standards.","order":1,"name":"Ethics","label":"Compliance with Ethical Standards","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"106"}}